By Project Phase
Clinical Study Close-Out
For biotech and pharmaceutical companies, medical device manufacturers, non-profit organizations, and academic institutions completing clinical studies involving drugs or medical devices that need to close study sites, verify the final dataset, and prepare regulatory reporting.
When the last patient completes participation in the study, the focus shifts from data collection to final verification: closing each site, ensuring dataset integrity, and providing the sponsor with a robust, well-documented report for the relevant regulatory authorities.
55+
Clinical studies
600 +
Investigators
300+
Hospitals
16k+
Patients
At study close-out, are you concerned about…
- A delayed database lock because the study data is not yet clean or complete.
- A clinical study report that does not stand up to regulatory scrutiny.
- Delays between the last patient visit and the submission of study results.
- Finalization
- Analysis
Close-Out Visit (COV)
We4 Clinical Research conducts close-out visits either on-site or remotely. These visits involve the completion of necessary documentation, assessment of study compliance, and the collection of any outstanding data or materials.
Clinical Study Report
We4 Clinical Research provides services to produce and review the Clinical Study Report (CSR). The CSR summarises the study’s objectives, methodology, results, and conclusions. We ensure that the CSR is accurate, comprehensive, and in compliance with regulatory requirements.
Statistical Analysis
We4 Clinical Research performs statistical analysis of the collected data. Our team employs advanced statistical methods and techniques to analyse the data and generate detailed reports of the findings. These reports provide valuable insights and support evidence-based decision-making.
What Conclusion activities include
Conclusion
Close-Out Visit (COV)
We conduct Close-Out Visits at the sites or remotely, completing the necessary documentation, assessing the study’s compliance and collecting any outstanding data or materials.
Data lock
We close open queries, complete the final validation and lock the study database, which from that moment is no longer modified and moves on to analysis.
End-of-study notification
We notify ethics committees and competent authorities of the end of the study within the timelines set by regulations.
Archiving
We close the Trial Master File and manage its archiving for the entire retention period required.
Analysis
Statistical analysis
We perform the statistical analysis of the collected data, with appropriate methods and techniques, for an interpretation of the results that supports decision-making.
Clinical study report
We produce and review the Clinical Study Report (CSR), the document that summarizes the objectives, methodology, results and conclusions of the study, in line with regulatory requirements.
Scientific publications
We support the drafting of manuscripts and conference abstracts based on the data and results of the study.
The We4CR Method
What guides us
Risk-based
Controls and resources always proportionate to the risk of each study.
Patient Centric
Studies designed around patients’ needs.
Quality over quantity
The rigor of our work comes before the numbers.
What you get in every study with We4CR
Tools developed by the We4 group support decentralized trials and operational flexibility, driving speed and quality without compromising compliance.
Site selection strategies and patient engagement tools help reduce recruitment delays and dropouts, containing cost overruns and making time-to-market more predictable.
Our digital solutions turn patients into active participants in the study, supporting retention and protecting the sponsor’s investment.
Services tailored to your study
Our flexible, modular way of working adapts to each sponsor’s operating model, so resources are used efficiently.
We build flexible, on-demand teams calibrated to the needs of each project, matching resources and expertise to the complexity of the study and its therapeutic area.
The same people follow your study from start to finish, with no internal handovers and a single point of contact who knows the whole history of the project.
We work with qualified local consultants when the project requires it.
Studies conducted
studies on medical devices
studies on drugs
International presence
European Union
7 countries
Non-EU countries
8 countries
People also ask…
We complete the necessary documentation, assess the study’s compliance and collect any outstanding data or materials.
At We4CR we produce and review the Clinical Study Report (CSR), the document that summarizes the objectives, methodology, results and conclusions of the study, in line with regulatory requirements.
After the close-out visit and the collection of any pending data, once the dataset is complete and verified. From that moment (the data lock) the data are no longer modified and we proceed with the statistical analysis.
It depends on the number of sites, the amount of data to be locked and the complexity of the statistical analysis. After an initial discovery call, we can outline timelines and steps for your case.
Absolutely. Our services are flexible and modular: you can add other phases to your study if you need them, or entrust us with the study from protocol to close-out right from the start. Discover all our CRO solutions.